Venture Capital
New York, New York, 10110
The Adjuvant model pursues meaningful, measurable social impact on top of its financial return objectives. Adjuvant’s strategy aims to drive meaningful improvements in the public health of low- and middle-income countries while pursuing top-tier financial returns. Adjuvant’s focus areas include: Neglected, high-burden, and emerging infectious diseases, including antimicrobial resistance and pandemic threats, Maternal, newborn, and child health challenges, Reproductive and sexual health, Nutrition. Adjuvant directs the majority of its investment activity to opportunities that have human efficacy signals from a phase II-or-later clinical trial or similar arm’s-length evaluations. We look for compelling proof-of-concept data to support our investment decisions. Adjuvant seeks out public health challenges where the burden is highest and the need is greatest
062224sbs
